{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:16:53Z","timestamp":1785557813425,"version":"3.56.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.tmaid.2022.102332","type":"journal-article","created":{"date-parts":[[2022,4,23]],"date-time":"2022-04-23T02:13:35Z","timestamp":1650680015000},"page":"102332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Is Omicron the end of pandemic or start of a new innings?"],"prefix":"10.1016","volume":"48","author":[{"given":"Swarnali","family":"Das","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sovan","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhimli","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitava","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biplab","family":"Giri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suvrendu Sankar","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5435-8556","authenticated-orcid":false,"given":"Sandeep Kumar","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tmaid.2022.102332_bib1","first-page":"8","article-title":"Corona virus: a review of COVID-19","volume":"4","author":"Kumar","year":"2020","journal-title":"EJMO"},{"key":"10.1016\/j.tmaid.2022.102332_bib2","first-page":"750","article-title":"Viral, host and environmental factors that favor anthropozoonotic spillover of coronaviruses: an opinionated review, focusing on SARS-CoV, MERS-CoV and SARS-CoV-2","volume":"141483","author":"Da Silva","year":"2021","journal-title":"Sci Total Environ"},{"key":"10.1016\/j.tmaid.2022.102332_bib3","article-title":"A novel coronavirus from patients with pneumonia in China","author":"Zhu","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2022.102332_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.clnesp.2022.02.007","article-title":"Alteration of dietary habits and lifestyle pattern during COVID-19 pandemic associated lockdown: an online survey study","author":"Samanta","year":"2022","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.tmaid.2022.102332_bib5","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2020013","article-title":"WHO international health regulations emergency committee for the COVID-19 outbreak","volume":"42","author":"Jee","year":"2020","journal-title":"Epidemiol Health"},{"issue":"6","key":"10.1016\/j.tmaid.2022.102332_bib7","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/21645515.2020.1735227","article-title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","volume":"16","author":"Dhama","year":"2020","journal-title":"Hum Vaccines Immunother"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102332_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-021-03662-x","article-title":"Emerging SARS-CoV-2 variants of concern and potential intervention approaches","volume":"25","author":"Khateeb","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.tmaid.2022.102332_bib9","first-page":"1","article-title":"Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review","author":"Das","year":"2022","journal-title":"Immunol Res"},{"issue":"6","key":"10.1016\/j.tmaid.2022.102332_bib10","first-page":"59","article-title":"Outbreak of coronavirus (SARS-CoV-2) Delta variant (B. 1.617. 2) and Delta plus (AY. 1) with fungal infections, mucormycosis: herbal medicine treatment","volume":"8","author":"Malabadi","year":"2021","journal-title":"Int J Res Sci Innovat"},{"issue":"11","key":"10.1016\/j.tmaid.2022.102332_bib11","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1038\/s41423-021-00772-y","article-title":"Delta variant (B. 1.617. 2) sublineages do not show increased neutralization resistance","volume":"18","author":"Arora","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.tmaid.2022.102332_bib12","article-title":"OMICRON (B. 1.1. 529): a new SARS-CoV-2 Variant of Concern mounting worldwide fear","author":"Thakur","year":"2021","journal-title":"J Med Virol"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102332_bib13","first-page":"15","article-title":"Omicron: the tsunami??","volume":"1","author":"Patil","year":"2022","journal-title":"Indian J Health Sci Biomd Res (KLEU)"},{"key":"10.1016\/j.tmaid.2022.102332_bib14","article-title":"Omicron, the great escape artist","author":"Flemming","year":"2022","journal-title":"Nat Rev Immunol"},{"issue":"50","key":"10.1016\/j.tmaid.2022.102332_bib15","doi-asserted-by":"crossref","first-page":"2101147","DOI":"10.2807\/1560-7917.ES.2021.26.50.2101147","article-title":"Outbreak caused by the SARS-CoV-2 omicron variant in Norway, November to December 2021","volume":"26","author":"Brandal","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/j.tmaid.2022.102332_bib16","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/d41586-022-00007-8","article-title":"Omicron's feeble attack on the lungs could make it less dangerous","author":"Kozlov","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2022.102332_bib17","article-title":"Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa","author":"Wolter","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.tmaid.2022.102332_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(22)00056-3","article-title":"Omicron severity: milder but not mild","author":"Nealon","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2022.102332_bib21","series-title":"Brief history of pandemics (pandemics throughout history). InPsychiatry of pandemics","first-page":"7","author":"Huremovi\u0107","year":"2019"},{"key":"10.1016\/j.tmaid.2022.102332_bib22","article-title":"Pandemics throughout history","volume":"3594","author":"Piret","year":"2021","journal-title":"Front Microbiol"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102332_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.28991\/SciMedJ-2021-0304-10","article-title":"A mini review on SARS-COVID-19-2 omicron variant (B. 1.1. 529)","volume":"3","author":"Ettaboina","year":"2021","journal-title":"SciMed J"},{"key":"10.1016\/j.tmaid.2022.102332_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27643","article-title":"The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant","author":"Tian","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2022.102332_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.110","article-title":"SARS-CoV-2 Omicron variant: characteristics and prevention","author":"He","year":"2021","journal-title":"MedComm"},{"key":"10.1016\/j.tmaid.2022.102332_bib27","article-title":"Omicron: a heavily mutated SARS-CoV-2 variant exhibits stronger binding to ACE2 and potently escape approved COVID-19 therapeutic antibodies","author":"Woo","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.tmaid.2022.102332_bib28","first-page":"126","article-title":"Omicron SARS-CoV-2 variant: unique features and their impact on pre-existing antibodies","volume":"102779","author":"Kannan","year":"2022","journal-title":"J Autoimmun"},{"issue":"10317","key":"10.1016\/j.tmaid.2022.102332_bib30","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1016\/S0140-6736(21)02758-6","article-title":"Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic","volume":"398","author":"Karim","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2022.102332_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27611","article-title":"Transmission dynamics and mutational prevalence of the novel SARS-CoV-2 Omicron Variant of Concern","author":"Saxena","year":"2022","journal-title":"J Med Virol"},{"issue":"50","key":"10.1016\/j.tmaid.2022.102332_bib32","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.15585\/mmwr.mm7050e1","article-title":"Team R. SARS-CoV-2 B. 1.1. 529 (omicron) variant\u2014United States, December 1\u20138, 2021","volume":"70","author":"COVID C","year":"2021","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102332_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.46234\/ccdcw2021.266","article-title":"The first two imported cases of SARS-CoV-2 omicron variant\u2014Tianjin municipality, China, December 13, 2021","volume":"4","author":"Tan","year":"2022","journal-title":"China CDC Weekly"},{"key":"10.1016\/j.tmaid.2022.102332_bib34","article-title":"Emergence of SARS-CoV-2 Omicron (B. 1.1. 529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic","volume":"112816","author":"Khandia","year":"2022","journal-title":"Environ Res"},{"key":"10.1016\/j.tmaid.2022.102332_bib36","first-page":"97","article-title":"Omicron variant (B. 1.1. 529) of SARS-CoV-2: threat assessment and plan of action","volume":"106187","author":"Choudhary","year":"2022","journal-title":"Int J Surg"},{"issue":"24","key":"10.1016\/j.tmaid.2022.102332_bib37","first-page":"8019","article-title":"Omicron (B. 1.1. 529)-variant of concern-molecular profile and epidemiology: a mini review","volume":"25","author":"Kannan","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.tmaid.2022.102332_bib38","article-title":"Features, evaluation, and treatment of coronavirus (COVID-19)","author":"Cascella","year":"2022","journal-title":"Statpearls [internet]"},{"issue":"6573","key":"10.1016\/j.tmaid.2022.102332_bib39","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.acx9782","article-title":"How bad is Omicron? Some clues are emerging","volume":"374","author":"Kupferschmidt","year":"2021","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102332_bib40","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jmv.27524","article-title":"Characterization of the novel SARS-CoV-2 Omicron (B. 1.1. 529) variant of concern and its global perspective","volume":"94","author":"Saxena","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2022.102332_bib41","first-page":"10","article-title":"The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant","volume":"100086","author":"Ali","year":"2021","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.tmaid.2022.102332_bib42","first-page":"45","article-title":"Highly mutated SARS-CoV-2 Omicron variant sparks significant concern among global experts\u2013What is known so far?","volume":"102234","author":"Poudel","year":"2022","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102332_bib43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.virol.2021.09.001","article-title":"Contribution of single mutations to selected SARS-CoV-2 emerging variants spike antigenicity","volume":"563","author":"Gong","year":"2021","journal-title":"Virology"},{"key":"10.1016\/j.tmaid.2022.102332_bib44","first-page":"45","article-title":"Omicron N501Y mutation among SARS-CoV-2 lineages: insilico analysis of potent binding to tyrosine kinase and hypothetical repurposed medicine","volume":"102242","author":"Kazybay","year":"2022","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.tmaid.2022.102332_bib45","article-title":"Omicron (BA. 1) and sub-variants (BA. 1, BA. 2 and BA. 3) of SARS-CoV-2 spike infectivity and pathogenicity: a comparative sequence and structural-based computational assessment","author":"Kumar","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.tmaid.2022.102332_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27601","article-title":"Emergence of Omicron third lineage BA. 3 and its importance","author":"Desingu","year":"2022","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2022.102332_bib47","first-page":"1","article-title":"Antibody evasion properties of SARS-CoV-2 Omicron sublineages","author":"Iketani","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2022.102332_bib48","article-title":"Covid-19: what do we know about omicron sublineages?","volume":"376","author":"Mahase","year":"2022","journal-title":"bmj"},{"key":"10.1016\/j.tmaid.2022.102332_bib49","author":"Wilkinson"},{"key":"10.1016\/j.tmaid.2022.102332_bib50","article-title":"Efficacy of antiviral agents against the SARS-CoV-2 omicron subvariant BA. 2","author":"Takashita","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmaid.2022.102332_bib51","doi-asserted-by":"crossref","unstructured":"Uraki R, Kiso M, Imai M, Yamayoshi S, Ito M, Ujie M, Furusawa Y, Iwatsuki-Horimoto K, Sakai-Tagawa Y, Kawaoka Y. Therapeutic efficacy of antibodies and antivirals against a SARS-CoV-2 Omicron variant. https:\/\/doi.org\/10.21203\/rs.3.rs-1240227\/v1.","DOI":"10.21203\/rs.3.rs-1240227\/v1"},{"issue":"7883","key":"10.1016\/j.tmaid.2022.102332_bib52","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B. 1.617. 2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2022.102332_bib53","article-title":"Omicron (B. 1.1. 529 variant of SARS-CoV-2); an emerging threat: current global scenario","author":"Mohapatra","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2022.102332_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27635","article-title":"The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue","author":"Daria","year":"2022","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102332_bib55","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/jmv.27526","article-title":"Omicron and Delta variant of SARS-CoV-2: a comparative computational study of spike protein","volume":"94","author":"Kumar","year":"2022","journal-title":"J Med Virol"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102332_bib56","first-page":"10","article-title":"Literature review of omicron: a Grim Reality amidst COVID-19","volume":"451","author":"Arora","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.tmaid.2022.102332_bib57","article-title":"From Delta to Omicron: S1-RBD\/S2 mutation\/deletion equilibrium in SARS-CoV-2 defined variants","volume":"146134","author":"Papanikolaou","year":"2022","journal-title":"Gene"},{"key":"10.1016\/j.tmaid.2022.102332_bib59","unstructured":"Bhoye S, Marakwad T. A comparative characteristics of both variants of severe Acute respiratory syndrome coronavirus-2 (SARS-CoV-2): Delta and Omicron."},{"key":"10.1016\/j.tmaid.2022.102332_bib61","article-title":"Culture and identification of a Deltamicron SARS-CoV-2 in a three cases cluster in southern France","author":"Colson","year":"2022","journal-title":"medRxiv"},{"issue":"7889","key":"10.1016\/j.tmaid.2022.102332_bib62","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/d41586-021-03672-3","article-title":"Omicron likely to weaken COVID vaccine protection","volume":"600","author":"Callaway","year":"2021","journal-title":"Nature"},{"issue":"7895","key":"10.1016\/j.tmaid.2022.102332_bib63","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/d41586-022-00214-3","article-title":"What the Omicron wave is revealing about human immunity","volume":"602","author":"Willyard","year":"2022","journal-title":"Nature"},{"issue":"7871","key":"10.1016\/j.tmaid.2022.102332_bib64","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/d41586-021-02158-6","article-title":"COVID vaccine boosters: the most important questions","volume":"596","author":"Callaway","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.tmaid.2022.102332_bib67","first-page":"1","article-title":"Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost","author":"Ai","year":"2021","journal-title":"Emerg Microb Infect"},{"issue":"7898","key":"10.1016\/j.tmaid.2022.102332_bib69","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"issue":"7898","key":"10.1016\/j.tmaid.2022.102332_bib70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.tmaid.2022.102332_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0008251","article-title":"Human plague: an old scourge that needs new answers","volume":"14","author":"Vall\u00e8s","year":"2020","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.tmaid.2022.102332_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.vacun.2022.01.002","article-title":"Awareness, knowledge and acceptance of COVID-19 vaccine among the people of West Bengal, India: a web-based survey","author":"Samanta","year":"2022","journal-title":"Vacunas"},{"key":"10.1016\/j.tmaid.2022.102332_bib77","series-title":"Brief history of pandemics (pandemics throughout history). InPsychiatry of pandemics","first-page":"7","author":"Huremovi\u0107","year":"2019"},{"issue":"12","key":"10.1016\/j.tmaid.2022.102332_bib78","doi-asserted-by":"crossref","first-page":"e3000506","DOI":"10.1371\/journal.pbio.3000506","article-title":"Patterns of smallpox mortality in London, England, over three centuries","volume":"18","author":"Krylova","year":"2020","journal-title":"PLoS Biol"},{"key":"10.1016\/j.tmaid.2022.102332_bib79","unstructured":"Lemon SM, Mahmoud A, Mack A, Knobler SL, editors. The threat of pandemic influenza: are we ready? workshop summary."},{"issue":"2","key":"10.1016\/j.tmaid.2022.102332_bib80","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1128\/CMR.00037-06","article-title":"Avian influenza virus (H5N1): a threat to human health","volume":"20","author":"Peiris","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tmaid.2022.102332_bib82","author":"Alexandridi"},{"key":"10.1016\/j.tmaid.2022.102332_bib83","first-page":"14","article-title":"Overview of the main anti-SARS-CoV-2 vaccines: mechanism of action, efficacy and safety","volume":"3459","author":"Mascellino","year":"2021","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.tmaid.2022.102332_bib84","first-page":"3","article-title":"Vaccines through centuries: major cornerstones of global health","volume":"269","author":"Hajj Hussein","year":"2015","journal-title":"Front Public Health"},{"issue":"1","key":"10.1016\/j.tmaid.2022.102332_bib85","doi-asserted-by":"crossref","first-page":"e35763","DOI":"10.2196\/35763","article-title":"Has omicron changed the evolution of the pandemic?","volume":"8","author":"Lundberg","year":"2022","journal-title":"JMIR Public Health Surveil"},{"issue":"4","key":"10.1016\/j.tmaid.2022.102332_bib86","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jama.2021.24315","article-title":"Winter of Omicron\u2014the evolving COVID-19 pandemic","volume":"327","author":"Del Rio","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2022.102332_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2022.02.005","article-title":"Substantial immune response in Omicron infected breakthrough and unvaccinated individuals against SARS-CoV-2 variants of concern","author":"Yadav","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/j.tmaid.2022.102332_bib91","first-page":"1","article-title":"Milder disease with Omicron: is it the virus or the pre-existing immunity?","author":"Sigal","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tmaid.2022.102332_bib92","doi-asserted-by":"crossref","DOI":"10.1007\/s10311-021-01369-7","article-title":"Will the COVID-19 pandemic end with the Delta and Omicron variants?","author":"Wang","year":"2022","journal-title":"Environ Chem Lett"},{"key":"10.1016\/j.tmaid.2022.102332_bib93","author":"Bugalia"},{"key":"10.1016\/j.tmaid.2022.102332_bib98","author":"Cooperman"},{"key":"10.1016\/j.tmaid.2022.102332_bib100","article-title":"Omicron (B. 1.1. 529 variant of SARS-CoV-2); an emerging threat: current global scenario","author":"Mohapatra","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2022.102332_bib101","article-title":"Emergence in Southern France of a new SARS-CoV-2 variant of probably Cameroonian origin harbouring both substitutions N501Y and E484K in the spike protein","author":"Colson","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.tmaid.2022.102332_bib102","doi-asserted-by":"crossref","DOI":"10.1002\/cbin.11800","article-title":"SARS-CoV-2 and influenza viruses: strategies to Cope with Co-infection and Bioinformatics perspective","author":"Ghaznavi","year":"2022","journal-title":"Cell Biol Int"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922000783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922000783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:22Z","timestamp":1761487642000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893922000783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":78,"alternative-id":["S1477893922000783"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102332","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is Omicron the end of pandemic or start of a new innings?","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102332","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102332"}}